CūtisCare Increasing Awareness This National Diabetes Month To Save Limbs and Lives

BOCA RATON, Fla., Nov. 14, 2021 /PRNewswire/ — CūtisCare, a leading provider of wound care management services to hospitals and physicians, is continuing our fight this month to raise awareness regarding diabetes and the available treatment options to help save limbs and lives. According to the CDC, diabetes currently adversely impacts the lives of approximately 34 million Americans, and that number is continuing to increase each year. About 25% of people with diabetes will develop foot ulcers, and 1% end up with an amputation in their lifetime. However, as many as 85% of potential amputations can be avoided when advanced modalities, such as hyperbaric oxygen therapy, or HBOT, are added to a treatment plan.

There is good news on the horizon though. Many of these amputations are preventable. HBOT is one therapy that is showing great promise. Louis Pilati MD, CutisCare’s Medical Advisory Board Member, expounds on the manifold benefits of HBOT for patients with Wagner Grade 3 or higher … read more

AmnioText from Regenative Labs

AmnioText™ patches are produced from human amniotic membranes and can be placed on the wound closure sites after a medical procedure or directly onto an open wound. The allografts are minimally manipulated and undergo an extensive and comprehensive testing process. The patches are produced in our first-class, state-of-the-art lab in Pensacola, Florida, to ensure the highest quality tissue allografts available. Click here to request more information